Three Serum MicroRNAs as Biomarkers for Bladder Cancer Detection
Author Information
Author(s): Ge Zhenjian, Lin Shengjie, Lu Chong, Xia Yong, Li Rongkang, Li Xinji, Sun Chen, Wen Zhenyu, Chen Wenkang, Li Yingqi, Li Mingyang, Lin Yu, Dong Jing, Tao Lingzhi, Ji Ling, Lai Yongqing
Primary Institution: Peking University Shenzhen Hospital
Hypothesis
Can a panel of serum microRNAs serve as effective biomarkers for the early detection of bladder cancer?
Conclusion
A three-miRNA panel was developed that could serve as a highly efficient and inexpensive biomarker for bladder cancer diagnosis and screening.
Supporting Evidence
- The three-miRNA panel showed an AUC of 0.838, indicating strong diagnostic capability.
- MiR-212-3p, miR-30c-5p, and miR-206 were identified as key biomarkers.
- The panel achieved a sensitivity of 83.33% and specificity of 73.81%.
Takeaway
The study found that three specific microRNAs in the blood can help doctors find bladder cancer early, which is important for better treatment.
Methodology
The study involved 112 bladder cancer patients and 112 healthy subjects, using qRT-PCR to analyze serum microRNA levels and develop a diagnostic panel.
Limitations
The sample size was relatively small, and only 10 miRNAs were investigated.
Participant Demographics
112 bladder cancer patients and 112 healthy controls, with no significant differences in age and gender.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI: 0.774-0.890
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website